National Comprehensive Cancer Network



About NCCN

Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenstrm's Macroglobulinemia Panel - Disclosures as of 9/27/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Melissa Alsina, MD

None

Onyx Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

1/21/2015

Kenneth C. Anderson, MD

None

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead Sciences;
sanofi-aventis U.S.

None

acetylon;
acetylon;
oncopep;
oncopep

None

1/23/2015

William Bensinger, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pharmacyclics

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

None

9/17/2014

J. Sybil Biermann, MD

None

None

None

None

None

5/2/2014

Jason C. Chandler, MD

None

Onyx Pharmaceuticals, Inc.

None

None

None

1/22/2015

Caitlin Costello, MD

None

None

None

None

None

1/26/2015

Steven Devine, MD

Genzyme Corporation

GlaxoSmithKline

None

None

None

5/22/2014

Benjamin Djulbegovic, MD, PhD

None

None

None

None

None

1/20/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Cristina Gasparetto, MD

None

Celgene Corporation;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

None

1/27/2015

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

None

9/25/2014

Carol Ann Huff, MD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation;
sanofi-aventis U.S.

None

None

None

1/21/2015

Adetola Kassim, MD, MS

None

None

None

None

None

1/16/2015

Amrita Y. Krishnan, MD, FACP

None

Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

Celgene Corporation;
Pharmacyclics

None

1/24/2015

Rashmi Kumar, PhD

None

None

None

None

None

11/7/2014

Michaela Liedtke, MD

None

None

None

None

None

1/18/2015

Matthew Lunning, DO

None

None

None

None

None

2/4/2015

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Ruby Meredith, MD, PhD

None

None

None

None

None

4/5/2013

Noopur Raje, MD

Amgen Inc.;
Eli Lilly and Company;
Acetylon

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

1/21/2015

Dorothy Shead, MS

None

None

None

None

None

2/18/2015

Seema Singhal, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

None

1/23/2015

George Somlo, MD

None

Celgene Corporation;
Genentech, Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Abraxane;
Abraxane;
Abraxane;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

None

None

1/21/2015

Keith Stockerl-Goldstein, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

1/21/2015

Steven P. Treon, MD, PhD

None

None

None

None

None

2/5/2015

Sarika Trikha, PharmD

None

None

None

None

None

11/11/2014

Donna M. Weber, MD

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

None

9/26/2013

Joachim Yahalom, MD

None

None

None

None

None

8/18/2014